Rising Pharma Holding, Inc. recalls
6 notices naming Rising Pharma Holding, Inc. as the recalling firm, since December 11, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Rising Pharma Holding, Inc.: Rising
Hazard (FDA): Presence of Precipitate: medication was crystallizing and particles floating in the bottle
FDAMedicines
Rising Pharma Holding, Inc.: Product label: Temozolomide Capsules
Hazard (FDA): Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
FDAMedicines
Rising Pharma Holding, Inc.: Carbidopa
Hazard (FDA): Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and…
FDAMedicines
Rising Pharma Holding, Inc.: Duloxetine Delayed-Release Capsules
Hazard (FDA): CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
FDAMedicines
Rising Pharma Holding, Inc.: Duloxetine Delayed-Release Capsules USP 30 mg and 2 more
Hazard (FDA): CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
FDAMedicines
Rising Pharma Holding, Inc.: Duloxetine Delayed-Release Capsules USP and 2 more
Hazard (FDA): CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
FDAMedicines